Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Korean National Tuberculosis Association (KNTA) is a leading public health organization in South Korea dedicated to the prevention and eradication of tuberculosis. Established in 1953, the association operates the Korean Institute of Tuberculosis (KIT), which serves as a national reference laboratory for diagnostic research and drug resistance monitoring. KNTA provides essential services including nationwide mobile X-ray screening, molecular diagnostics, and the domestic production of the BCG vaccine. The organization is also widely recognized for its annual Christmas Seal fundraising campaign, which supports TB control initiatives and international health cooperation. Through its comprehensive approach, KNTA plays a pivotal role in South Korea's national health strategy and global infectious disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korean National Tuberculosis Association.